Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipid metabolism disorders
ADR ID BADD_A01285
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
Description Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body. [MeSH]
MedDRA Code 10013317
MeSH ID D052439
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipid Metabolism Disorders | Lipid Metabolism Disorder | Metabolism Disorder, Lipid | Metabolism Disorders, Lipid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01204Isoniazid--
BADD_D01211Isosorbide mononitrate--
BADD_D01213Isotretinoin0.014408%
BADD_D01217Itraconazole0.005345%
BADD_D01230Ketoconazole0.000066%
BADD_D01231Ketoprofen--
BADD_D01242Lamivudine0.004554%
BADD_D01243Lamotrigine--
BADD_D01244Lanreotide acetate--
BADD_D01245Lansoprazole--
BADD_D01250Lasofoxifene--
BADD_D01252Leflunomide0.002185%
BADD_D01253Lenalidomide--
BADD_D01254Lenvatinib--
BADD_D01255Lercanidipine--
BADD_D01257Letrozole0.002292%
BADD_D01258Leucovorin--
BADD_D01260Leuprolide acetate0.001434%
BADD_D01261Leuprolide monoacetate--
BADD_D01265Levetiracetam--
BADD_D01266Levobetaxolol hydrochloride--
BADD_D01275Levofloxacin0.000063%
BADD_D01281Levonorgestrel0.000946%
BADD_D01285Levothyroxine0.000027%
BADD_D01292Linagliptin--
BADD_D01295Linezolid0.007410%
BADD_D01300Lisinopril--
BADD_D01304Lithium cation--
BADD_D01311Lomitapide--
BADD_D01312Lomitapide mesylate--
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 15 Pages
ADReCS-Target
ADR Term Drug Name Target